Nile Therapeutics, Inc. (NLTX) has 29 open-market insider trades by 14 insiders since 2008. The most active filer is Jonathan G. Drachman, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| 667, L.P. | Dir | — | 1 | $27.4M | 2019-12-20 |
| Julian Baker | Dir | — | 1 | $6.5M | 2020-07-07 |
| Jonathan G. Drachman | CEOPres | — | 4 | $4.8M | 2021-08-25 |
| Jeremy Green | 10% Owner | — | 1 | $2.9M | 2020-04-02 |
| Baker Brothers Life Sciences LP | Dir10% Owner | — | 1 | $2.9M | 2023-08-17 |
| Robert Ho | CFO | — | 1 | $143K | 2021-03-17 |
| Priti Patel | — | — | 3 | $18K | 2023-04-03 |
| Joshua A. Kazam | Dir | — | 4 | $16K | 2009-03-12 |
| Daron Evans | CFO | — | 3 | $15K | 2009-03-13 |
| David M. Tanen | Dir | — | 3 | $14K | 2008-12-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Baker Brothers Life Sciences LP | Director & 10% Owner | Buy | $2.9M | 2023-08-15 |
| Sean Michael Smith | Interim CFO & Prin Acct Off | Sell | $820 | 2023-08-11 |
| Priti Patel | — | Sell | $3K | 2023-04-03 |
| Sean Michael Smith | Principal Accounting Officer | Sell | $2K | 2023-02-02 |
| Priti Patel | Chief Medical Officer | Sell | $9K | 2023-02-02 |
| Sean Michael Smith | Principal Accounting Officer | Sell |
Companies that share insiders with NLTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $2K |
| 2022-08-10 |
| Priti Patel | Chief Medical Officer | Sell | $7K | 2022-05-02 |
| Jonathan G. Drachman | CEO & President | Buy | $772K | 2021-08-24 |
| Carl Walkey | President & VP | Sell | $6K | 2021-06-16 |
| Carl Walkey | President & VP | Sell | $7K | 2021-06-09 |
| Carl Walkey | President & VP | Sell | $7K | 2021-06-08 |
| Carl Walkey | President & VP | Sell | $6K | 2021-06-04 |
| Jonathan G. Drachman | CEO & President | Buy | $475K | 2021-06-03 |
| Carl Walkey | President & VP | Sell | $6K | 2021-05-26 |
| Carl Walkey | President & VP | Sell | $6K | 2021-05-19 |